These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11879748)

  • 1. Preparation, characterization, and tabletting properties of a new cellulose-based pharmaceutical aid.
    Kumar V; de la Luz Reus-Medina M; Yang D
    Int J Pharm; 2002 Mar; 235(1-2):129-40. PubMed ID: 11879748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the powder properties and compression behaviour of a new cellulose-based direct compression excipient and Avicel PH-102.
    Reus-Medina M; Lanz M; Kumar V; Leuenberger H
    J Pharm Pharmacol; 2004 Aug; 56(8):951-6. PubMed ID: 15285837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified cellulose II powder: preparation, characterization, and tableting properties.
    de la Luz Reus Medina M; Kumar V
    J Pharm Sci; 2007 Feb; 96(2):408-20. PubMed ID: 17075860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of powder and tableting properties of low and high degree of polymerization cellulose I and cellulose II excipients.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2007 Jun; 337(1-2):202-9. PubMed ID: 17376616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions.
    Kumar V; Kothari SH; Banker GS
    AAPS PharmSciTech; 2001 May; 2(2):E7. PubMed ID: 14727882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray-dried cellulose nanofibers as novel tablet excipient.
    Kolakovic R; Peltonen L; Laaksonen T; Putkisto K; Laukkanen A; Hirvonen J
    AAPS PharmSciTech; 2011 Dec; 12(4):1366-73. PubMed ID: 22005956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline celluloses, and powdered celluloses.
    Kothari SH; Kumar V; Banker GS
    Int J Pharm; 2002 Jan; 232(1-2):69-80. PubMed ID: 11790491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcrystalline cellulose from soybean hull as an excipient in solid dosage forms: Preparation, powder characterization, and tableting properties.
    Alamdari NE; Aksoy B; Babu RJ; Jiang Z
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132298. PubMed ID: 38750863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Vitacel M80K as a new direct compressible vehicle.
    Nada AH; Graf E
    Eur J Pharm Biopharm; 1998 Nov; 46(3):347-53. PubMed ID: 9885308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compression parameters of hexagonal boron nitride on direct compression mixture of microcrystalline cellulose and modified starch.
    Halaçoğlu MD; Uğurlu T
    Pharm Dev Technol; 2015; 20(6):747-54. PubMed ID: 24841191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The firmness of Avicel PH 102 and Avicel PH 301 compression and the effect of magnesium stearate] ].
    Muzíková J
    Ceska Slov Farm; 2001 Mar; 50(2):92-4. PubMed ID: 11288597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of near-infrared spectroscopy for nondestructive analysis of Avicel powders and tablets.
    Ebube NK; Thosar SS; Roberts RA; Kemper MS; Rubinovitz R; Martin DL; Reier GE; Wheatley TA; Shukla AJ
    Pharm Dev Technol; 1999 Jan; 4(1):19-26. PubMed ID: 10027209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental investigation of temperature rise during compaction of pharmaceutical powders.
    Krok A; Mirtic A; Reynolds GK; Schiano S; Roberts R; Wu CY
    Int J Pharm; 2016 Nov; 513(1-2):97-108. PubMed ID: 27601333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
    Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of processing and polymorphic form effect on the powder and tableting properties of microcrystalline celluloses I and II.
    Rojas J; López A; Gamboa Y; González C; Montoya F
    Chem Pharm Bull (Tokyo); 2011; 59(5):603-7. PubMed ID: 21532198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary studies of the development of a direct compression cellulose excipient from bagasse.
    Padmadisastra Y; Gonda I
    J Pharm Sci; 1989 Jun; 78(6):508-14. PubMed ID: 2760828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tabletting behaviour of pellets of a series of porosities--a comparisonbetween pellets of two different compositions.
    Nicklasson F; Johansson B; Alderborn G
    Eur J Pharm Sci; 1999 Apr; 8(1):11-7. PubMed ID: 10072474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roller compaction of different pseudopolymorphic forms of theophylline: Effect on compressibility and tablet properties.
    Hadzović E; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Aug; 396(1-2):53-62. PubMed ID: 20600735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.